leisure time -WSS

leisure time

author：focus 2025-09-28 21:58:40 - browse：899

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Federal weight loss drug coverage is 30 years out of date

focus

WSS

How to make over

The FDA must approve intranasal treatments for anaphylaxis

Abortion policy in the spotlight at Republican debate

Listen: Vivek Ramaswamy's star turn & leaky drug data

Morgan Health, with ambitious aims, wants you to know it’s still here

Morgan Health, with ambitious aims, wants you to know it’s still here

hotspot

leisure time

hotspot

In Memoriam: Notable people who died in 2023

Trans patients at the end of life deserve respect and dignity

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Morgan Health, with ambitious aims, wants you to know it’s still here

BioMarin wins approval for gene therapy to treat hemophilia A

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Peter Hotez and the public health issue of online harassment

JPM: CVS says Medicare Advantage patients are impacting profits

23andMe had bad news about my health. I wish a person had delivered it

AdventHealth escalates lawsuit against insurance vendor Multiplan

entertainment

Can U.S. cancer drug shortages be fixed?

How the first Native Hawaiian psychiatrist helped diversify medicine

How the first Native Hawaiian psychiatrist helped diversify medicine

Listen: Vivek Ramaswamy's star turn & leaky drug data

Hospital at home shows how to bring innovation to health care

White House finalizes ITC's import ban of latest Apple Watches

focus

hotspot

focus

knowledge